Ionis Pharmaceuticals (IONS) Total Debt (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Total Debt of $432.5 million for Q1 2026, down 5.99% quarter-over-quarter from $460.1 million in Q4 2025.
Ionis Pharmaceuticals (IONS) Total Debt (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Total Debt history runs 18 years deep, the most recent figure standing at $432.5 million for Q1 2026.
- In Q1 2026, Total Debt changed N/A year-over-year to $432.5 million; the TTM figure through Mar 2026 stood at $432.5 million (changed N/A YoY), while the FY2025 annual figure was $460.1 million, up 786.04% from the prior year.
- Total Debt for Q1 2026 stood at $432.5 million, down from $460.1 million in the prior quarter.
- The five-year high for Total Debt was $630.9 million in Q3 2025, with the low at $8.8 million in Q1 2023.
- The 5-year median for Total Debt is $63.8 million (2022), against an average of $188.7 million.
- The sharpest annual moves came in 2023 and 2025: Total Debt sank 86.16% in 2023, then jumped 1318.83% in 2025.
- Ionis Pharmaceuticals' Total Debt stood at $16.0 million in 2022, then surged by 439.46% to $86.2 million in 2023, then slumped by 39.74% to $51.9 million in 2024, then soared by 786.04% to $460.1 million in 2025, then dropped by 5.99% to $432.5 million in 2026.
- Business Quant data shows IONS's Total Debt at $432.5 million in Q1 2026, $460.1 million in Q4 2025, and $630.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 432.50 Mn |
| Dec 31, 2025 | 460.07 Mn |
| Sep 30, 2025 | 630.91 Mn |
| Jun 30, 2025 | 630.12 Mn |
| Dec 31, 2024 | 51.92 Mn |
| Sep 30, 2024 | 44.47 Mn |
| Jun 30, 2024 | 44.42 Mn |
| Mar 31, 2024 | 44.38 Mn |
| Dec 31, 2023 | 86.17 Mn |
| Mar 31, 2023 | 8.81 Mn |
| Dec 31, 2022 | 15.97 Mn |
| Sep 30, 2022 | 63.95 Mn |
| Jun 30, 2022 | 63.95 Mn |
| Mar 31, 2022 | 63.67 Mn |
| Dec 31, 2021 | 63.24 Mn |
| Sep 30, 2021 | 121.89 Mn |
| Jun 30, 2021 | 121.90 Mn |
| Mar 31, 2021 | 121.82 Mn |
| Dec 31, 2020 | 368.79 Mn |
| Sep 30, 2020 | 65.82 Mn |